Our data reveal a pivotal function for Drp1 in mediating tumor growth, mitochondrial fission, and cell cycle in cutaneous SCCs (Figure 2), suggesting that Drp1 could be a novel target for cutaneous SCC therapies. This evidence concerns the gene DNM1L and neoplasm.